Olopade O I, Buchhagen D L, Malik K, Sherman J, Nobori T, Bader S, Nau M M, Gazdar A F, Minna J D, Diaz M O
Department of Medicine, University of Chicago, Illinois 60637.
Cancer Res. 1993 May 15;53(10 Suppl):2410-5.
Cytogenetic analyses of non-small cell lung cancer have revealed deletions of the short arm of chromosome 9 with breakpoints at 9p11-pter in a significant proportion of tumors. Recent evidence suggests that homozygous loss of the interferon (IFN) and methylthioadenosine phosphorylase (MTAP) genes located on 9p and a tumor suppressor gene closely linked to them is associated with acute lymphoblastic leukemia and with gliomas. We have observed alterations of DNA sequences on 9p which include the IFN genes at a significant frequency in all types of human lung cancers (20 of 56 or 36%). The genetic alterations observed include homozygous or hemizygous deletions of the IFN genes as well as rearrangement of contiguous DNA sequences. In addition to these genomic alterations, 10 of 22 (45%) cell lines examined lacked MTAP enzyme activity. Overall, 24 of 56 (43%) lung cancer cell lines examined had hemizygous or homozygous loss of DNA sequences which include the IFN or MTAP genes. These findings suggest that the putative tumor suppressor gene at this locus contributes to the malignant process in lung cancers, as well as other types of human cancer.
非小细胞肺癌的细胞遗传学分析显示,在相当比例的肿瘤中存在9号染色体短臂缺失,断点位于9p11 - pter。最近的证据表明,位于9p的干扰素(IFN)和甲硫腺苷磷酸化酶(MTAP)基因的纯合缺失以及与之紧密连锁的一个肿瘤抑制基因与急性淋巴细胞白血病和神经胶质瘤有关。我们观察到在所有类型的人类肺癌中,9p上包括IFN基因在内的DNA序列改变频率很高(56例中有20例,占36%)。观察到的基因改变包括IFN基因的纯合或半合子缺失以及相邻DNA序列的重排。除了这些基因组改变外,在检测的22个细胞系中有10个(45%)缺乏MTAP酶活性。总体而言,在检测的56个肺癌细胞系中有24个(43%)存在包括IFN或MTAP基因在内的DNA序列的半合子或纯合子缺失。这些发现表明,该位点的假定肿瘤抑制基因在肺癌以及其他类型的人类癌症的恶性进程中发挥作用。